Ca_v 1.3 (CACNA1D) L-type Ca²⁺ channel dysfunction in CNS disorders

Area of Science:

• Neuroscience
• Genetics
• Channelopathies

Background:

• Calcium voltage-gated channel subunit alpha1 D (Ca v 1.3) channels, encoded by CACNA1D, are crucial for neuronal function, plasticity, and hormone secretion.
• While loss of Ca v 1.3 function doesn't cause neurological issues, enhanced activity is implicated in disease.
• CACNA1D mutations have been identified in primary aldosteronism and neurological conditions.

Purpose of the Study:

• To investigate the role of CACNA1D mutations in the development of central nervous system (CNS) disorders.
• To determine if gain-of-function mutations in CACNA1D confer risk for neuropsychiatric diseases, including autism spectrum disorder (ASD).

Main Methods:

• Analysis of whole exome sequencing data from patients with primary aldosteronism.
• Characterization of de novo CACNA1D missense mutations.
• Assessment of Ca v 1.3 channel activity and signaling in response to identified mutations.

Main Results:

• De novo CACNA1D missense mutations leading to enhanced Ca v 1.3 channel activity were identified.
• Individuals with these gain-of-function mutations exhibited seizures and neurological abnormalities, beyond primary aldosteronism.
• Similar gain-of-function mutations were found in patients diagnosed with autism spectrum disorders (ASD).

Conclusions:

• Mutations that enhance Ca v 1.3 channel activity significantly increase the risk for CNS disorders.
• CACNA1D mutations are strongly implicated as a cause or major risk factor for conditions such as ASD and epilepsy.
• Targeting Ca v 1.3 channel activity may offer therapeutic potential for these neurological conditions.